This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid19_influenza_macrophage_XXX
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid19_influenza_macrophage_XXX.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org

1. Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity.

Eur J Immunol 2014; 44 (7): 2003-12

PMC4883102 2. Lethal influenza infection: Is a macrophage to blame?

Expert Rev Anti Infect Ther 2015; 13 (12): 1425-8

PMC6056608 3. Highly Pathogenic H5N1 Influenza A Virus Spreads Efficiently in Human Primary Monocyte-Derived Macrophages and Dendritic Cells.

Front Immunol 2018; 9 (ä): 1664

PMC6037688 4. Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus.

Front Immunol 2018; 9 (ä): 1521

PMC5624992 5. Induction of Apoptosis and Subsequent Phagocytosis of Virus-Infected Cells As an Antiviral Mechanism.

Front Immunol 2017; 8 (ä): 1220

PMC6831648 6. Interleukin-37 Ameliorates Influenza Pneumonia by Attenuating Macrophage Cytokine Production in a MAPK-Dependent Manner.

Front Microbiol 2019; 10 (ä): 2482

PMC5331050 7. Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.

Front Microbiol 2017; 8 (ä): 276

8. Role for autophagy in cellular response to influenza virus infection.

Hong Kong Med J 2014; 20 Suppl 6 (ä): 20-4

9. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

Immunity 2014; 40 (4): 554-68

PMC3243824 10. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza.

Immunol Lett 2012; 141 (2): 227-34

PMC3516032 11. Resolution of immune response by recombinant transforming growth factor-beta (rTGF-beta) during influenza A virus infection.

Indian J Med Res 2012; 136 (4): 641-8

PMC3780943 12. The battle between influenza and the innate immune response in the human respiratory tract.

Infect Chemother 2013; 45 (1): 11-21

PMC5596526 13. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-kappaB signaling pathway.

Influenza Other Respir Viruses 2017; 11 (5): 457-463

PMC4942046 14. Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung.

Influenza Other Respir Viruses 2011; 5 (5): 343-50

PMC6163364 15. Monocytes and Macrophages as Viral Targets and Reservoirs.

Int J Mol Sci 2018; 19 (9): ä

PMC5217687 16. AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling.

J Biol Chem 2017; 292 (1): 292-304

PMC4811131 17. Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection.

J Clin Invest 2016; 126 (4): 1566-80

PMC4811146 18. Influenza leaves a TRAIL to pulmonary edema.

J Clin Invest 2016; 126 (4): 1245-7

PMC424144 19. Macrophages are required for influenza virus infection of human lymphocytes.

J Clin Invest 1987; 79 (2): 620-4

PMC2442640 20. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.

J Exp Med 2008; 205 (7): 1621-34

PMC2605231 21. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand.

J Exp Med 2008; 205 (13): 3065-77

PMC2192790 22. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.

J Exp Med 1996; 184 (3): 1191-6

PMC2137958 23. HISTOCHEMICAL STUDIES OF LYSOSOMES AND LYSOSOMAL ENZYMES IN VIRUS-INFECTED CELL CULTURES.

J Exp Med 1965; 121 (ä): 463-76

PMC2136484 24. Studies of influenza infection in ferrets by means of fluorescein-labelled antibody. I. The pathogenesis and diagnosis of the disease.

J Exp Med 1955; 101 (6): 665-76

PMC2135962 25. PULMONARY EDEMA IN INFLUENZAL PNEUMONIA OF THE MOUSE AND THE RELATION OF FLUID IN THE LUNG TO THE INCEPTION OF PNEUMOCOCCAL PNEUMONIA.

J Exp Med 1950; 91 (3): 245-60

PMC5725990 26. Influenza virus replication in macrophages: balancing protection and pathogenesis.

J Gen Virol 2017; 98 (10): 2401-2412

PMC4635478 27. Susceptibility of bone marrow-derived macrophages to influenza virus infection is dependent on macrophage phenotype.

J Gen Virol 2015; 96 (10): 2951-2960

PMC6089355 28. IL-36gamma Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.

J Immunol 2018; 201 (2): 573-582

PMC5809299 29. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.

J Immunol 2018; 200 (4): 1425-1433

PMC5439025 30. AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.

J Immunol 2017; 198 (11): 4383-4393

PMC5751439 31. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.

J Immunol 2017; 198 (4): 1616-1626

PMC5557035 32. Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice.

J Immunol 2017; 199 (3): 1060-1068

PMC3965630 33. Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.

J Immunol 2014; 192 (7): 3301-7

PMC4907362 34. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.

J Immunol 2013; 191 (3): 1250-9

35. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease.

J Immunol 2012; 189 (2): 946-55

36. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

J Immunol 2010; 184 (4): 2048-56

37. Actin and RIG-I/MAVS signaling components translocate to mitochondria upon influenza A virus infection of human primary macrophages.

J Immunol 2009; 182 (9): 5682-92

38. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.

J Immunol 2008; 180 (4): 2562-72

39. Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-gamma production by phagocytic cells.

J Immunol 2007; 179 (1): 247-55

40. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

J Immunol 2007; 178 (4): 2448-57

41. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.

J Immunol 2002; 169 (11): 6193-201

42. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

J Immunol 2001; 167 (10): 5868-73

43. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections.

J Immunol 2001; 166 (12): 7381-8

44. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.

J Immunol 1999; 162 (12): 7322-9

PMC6757286 45. The Role of Innate Leukocytes during Influenza Virus Infection.

J Immunol Res 2019; 2019 (ä): 8028725

PMC4779301 46. Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

J Infect Dis 2016; 213 (7): 1180-8

PMC6738265 47. Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

J Innate Immun 2019; 11 (4): 316-329

PMC5610570 48. Frontline Science: Coincidental null mutation of Csf2ralpha in a colony of PI3Kgamma-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection.

J Leukoc Biol 2017; 101 (2): 367-376

PMC3975085 49. Editorial: macrophage heterogeneity and responses to influenza virus infection.

J Leukoc Biol 2012; 92 (1): 1-4

PMC3382316 50. Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages.

J Leukoc Biol 2012; 92 (1): 11-20

PMC2752015 51. Innate immune control and regulation of influenza virus infections.

J Leukoc Biol 2009; 86 (4): 803-12

PMC4789761 52. 1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

J Pathol 2016; 238 (1): 85-97

PMC6744253 53. Serial Section Array Scanning Electron Microscopy Analysis of Cells from Lung Autopsy Specimens following Fatal A/H1N1 2009 Pandemic Influenza Virus Infection.

J Virol 2019; 93 (19): ä

PMC6475778 54. PPAR-gamma in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.

J Virol 2019; 93 (9): ä

PMC6364019 55. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.

J Virol 2019; 93 (4): ä

PMC5215328 56. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

J Virol 2017; 91 (2): ä

PMC4136329 57. Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.

J Virol 2014; 88 (17): 10214-27

PMC3372212 58. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque.

J Virol 2012; 86 (11): 6055-66

PMC3126566 59. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

J Virol 2011; 85 (14): 6844-55

PMC3004299 60. Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.

J Virol 2010; 84 (24): 12564-75

PMC2897615 61. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

J Virol 2010; 84 (15): 7569-80

PMC2293066 62. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs.

J Virol 2008; 82 (9): 4265-74

PMC2258992 63. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice.

J Virol 2008; 82 (6): 2772-83

PMC1287592 64. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

J Virol 2005; 79 (23): 14933-44

PMC516400 65. Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina).

J Virol 2004; 78 (19): 10420-32

PMC136427 66. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection.

J Virol 2002; 76 (18): 9298-306

PMC102123 67. Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages.

J Virol 2000; 74 (19): 9240-4

PMC111841 68. Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages.

J Virol 2000; 74 (7): 3399-403

PMC230250 69. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection.

J Virol 1997; 71 (12): 9450-7

PMC189945 70. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.

J Virol 1996; 70 (2): 1288-91

PMC254818 71. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.

J Virol 1985; 54 (2): 467-72

PMC255619 72. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis.

J Virol 1984; 50 (2): 287-92

73. Tissue kallikrein regulates alveolar macrophage apoptosis early in influenza virus infection.

Am J Physiol Lung Cell Mol Physiol 2019; 316 (6): L1127-L1140

74. Halothane inhibits the intraalveolar recruitment of neutrophils, lymphocytes, and macrophages in response to influenza virus infection in mice.

Anesth Analg 1993; 76 (5): 1106-13

75. Proliferation of lung macrophages in acute fatal viral infections in chickens.

Avian Dis 2001; 45 (4): 813-8

76. Augmentation of fatality of influenza in mice by inhibition of phagocytosis.

Biochem Biophys Res Commun 2005; 337 (3): 881-6

77. Turning off NADPH oxidase-2 by impeding p67(phox) activation in infected mouse macrophages reduced viral entry and inflammation.

Biochim Biophys Acta Gen Subj 2018; 1862 (6): 1263-1275

78. Changes in the Structure of Mouse Kidney in the Acute Period after Infection with Influenza Viruses A/H5N1 and A/H1N1.

Bull Exp Biol Med 2019; 166 (3): 358-363

79. Pulmonary inflammatory response to influenza virus infection in pigs is regulated by DAP12 and macrophage M1 and M2 phenotypes.

Cell Immunol 2020; ä (ä): 104078

80. Influenza A virus interactions with macrophages: Lessons from epithelial cells.

Cell Microbiol 2020; ä (ä): e13170

81. Qiangzhi decoction protects mice from influenza A pneumonia through inhibition of inflammatory cytokine storm.

Chin J Integr Med 2015; 21 (5): 376-83

82. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production.

Clin Exp Pharmacol Physiol 2018; 45 (1): 84-93

83. Immunopathology in influenza virus infection: uncoupling the friend from foe.

Clin Immunol 2012; 144 (1): 57-69

84. Acquired disorders of phagocyte function complicating medical and surgical illnesses.

Clin Infect Dis 2001; 33 (12): 2040-8

85. Characterization of influenza virus-induced death of J774.1 macrophages.

Exp Cell Res 1997; 234 (2): 249-58

86. The influenza virus--infected phagocyte. A model of deactivation.

Hematol Oncol Clin North Am 1988; 2 (2): 301-15

87. The distinctive features of influenza virus infection of dendritic cells.

Immunobiology 1998; 198 (5): 552-67

88. The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis.

Immunol Cell Biol 2017; 95 (3): 225-235

89. In vitro resistance to influenza virus infection of macrophages induced by BCG.

Indian J Med Res 1977; 66 (6): 889-94

90. Cytokines and neutrophils responses in influenza pneumonia.

Infection 2013; 41 (5): 1021-4

91. Pro-inflammatory cytokine dysregulation is associated with novel avian influenza A (H7N9) virus in primary human macrophages.

J Gen Virol 2016; 97 (2): 299-305

92. Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis.

J Gen Virol 2002; 83 (Pt 9): 2109-2116

93. Differentiation of monocytes to macrophages induced by influenza virus-infected apoptotic cells.

J Gen Virol 2002; 83 (Pt 4): 747-751

94. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection.

J Gen Virol 1987; 68 ( Pt 2) (ä): 425-32

95. Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus.

J Gen Virol 1987; 68 ( Pt 2) (ä): 419-24

96. Pregnancy Induces a Steady-State Shift in Alveolar Macrophage M1/M2 Phenotype That Is Associated With a Heightened Severity of Influenza Virus Infection: Mechanistic Insight Using Mouse Models.

J Infect Dis 2019; 219 (11): 1823-1831

97. Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production.

J Infect Dis 2014; 209 (11): 1827-36

98. Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.

J Infect Dis 2013; 207 (10): 1576-84

99. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity.

J Infect Dis 2013; 207 (8): 1270-80

100. Influenza A viruses target type II pneumocytes in the human lung.

J Infect Dis 2012; 206 (11): 1685-94

101. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades.

J Infect Dis 2011; 204 (12): 1866-78

102. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses.

J Infect Dis 2009; 200 (6): 858-65

103. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.

J Infect Dis 2008; 198 (4): 525-35

104. Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines.

J Int Med Res 2008; 36 (2): 322-8

105. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.

J Leukoc Biol 2012; 91 (3): 357-68

106. The ability of polymorphonuclear leukocyte priming agents to overcome influenza A virus-induced cell dysfunction.

J Leukoc Biol 1991; 50 (2): 160-6

107. Influenza A virus and the neutrophil: a model of natural immunity.

J Leukoc Biol 1990; 47 (2): 176-86

108. Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice.

J Med Virol 2019; 91 (3): 361-369

109. Influenza virus replication in human alveolar macrophages.

J Med Virol 1982; 9 (3): 177-84

110. Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models.

J Microbiol 2010; 48 (5): 657-62

111. DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality.

J Mol Med (Berl) 2015; 93 (10): 1131-43

112. Proteomic and Bioinformatic Characterization of Extracellular Vesicles Released from Human Macrophages upon Influenza A Virus Infection.

J Proteome Res 2017; 16 (1): 217-227

113. Antigenic variant of swine influenza virus causing proliferative and necrotizing pneumonia in pigs.

J Vet Diagn Invest 1992; 4 (4): 380-92

114. The cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens.

Lab Anim (NY) 2013; 42 (5): 170-6

PMC6675563 115. Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment.

JCI Insight 2019; 4 (14): ä

PMC5374077 116. M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.

JCI Insight 2017; 2 (7): e91868

117. Pathological examination of lung tissues in influenza a virus-infected mice.

Jpn J Infect Dis 2012; 65 (5): 383-91

118. Sudden death of a patient with pandemic influenza (A/H1N1pdm) virus infection by acute respiratory distress syndrome.

Jpn J Infect Dis 2010; 63 (1): 72-4

119. H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam.

Jpn J Infect Dis 2008; 61 (2): 157-60

PMC6283619 120. TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury.

Lung 2018; 196 (6): 737-743

PMC6548309 121. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis.

Matrix Biol 2019; 80 (ä): 14-28

PMC6509193 122. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.

mBio 2019; 10 (3): ä

PMC5371412 123. Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.

mBio 2017; 8 (2): ä

124. Lung histopathological findings in fatal pandemic influenza A (H1N1).

Med Intensiva 2012; 36 (1): 24-31

PMC3865735 125. Glucocorticosteroid in treatment of severe pneumonia.

Mediators Inflamm 2013; 2013 (ä): 865635

PMC3530802 126. Macrophage-mediated inflammation and disease: a focus on the lung.

Mediators Inflamm 2012; 2012 (ä): 140937

PMC1781695 127. Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice.

Mediators Inflamm 2001; 10 (2): 93-6

128. Contribution of neutrophil-derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infection.

Microbiol Immunol 2012; 56 (3): 171-82

129. Inhibitory role of neutrophils on influenza virus multiplication in the lungs of mice.

Microbiol Immunol 2001; 45 (10): 679-88

130. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam.

Mod Pathol 2013; 26 (3): 357-69

PMC4969252 131. Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy?

Mol Cell Pediatr 2016; 3 (1): 29

PMC6094359 132. EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury.

Mol Ther 2018; 26 (8): 2060-2069

PMC6301097 133. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection.

Mucosal Immunol 2019; 12 (1): 223-231

PMC6301110 134. Airway epithelial cells prime plasmacytoid dendritic cells to respond to pathogens via secretion of growth factors.

Mucosal Immunol 2019; 12 (1): 77-84

PMC5638662 135. Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.

Mucosal Immunol 2018; 11 (1): 199-208

PMC5471142 136. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia.

Mucosal Immunol 2017; 10 (4): 1043-1055

PMC4430298 137. The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung.

Mucosal Immunol 2015; 8 (5): 1021-1030

PMC5635038 138. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.

Nat Commun 2017; 8 (1): 846

PMC3715851 139. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages.

Nat Commun 2013; 4 (ä): 2106

PMC3417123 140. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

Nat Immunol 2011; 12 (7): 631-8

PMC2857582 141. Influenza virus activates inflammasomes via its intracellular M2 ion channel.

Nat Immunol 2010; 11 (5): 404-10

PMC3424101 142. Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes.

Nat Immunol 2010; 11 (5): 427-34

PMC6322907 143. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.

Nat Med 2005; 11 (11): 1180-7

PMC6026066 144. A naturally occurring antiviral ribonucleotide encoded by the human genome.

Nature 2018; 558 (7711): 610-614

PMC4777525 145. An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway.

PLoS Biol 2016; 14 (3): e1002364

PMC6777801 146. Macrophage PPAR-gamma suppresses long-term lung fibrotic sequelae following acute influenza infection.

PLoS One 2019; 14 (10): e0223430

PMC5650162 147. Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice.

PLoS One 2017; 12 (10): e0186639

PMC5501455 148. Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia.

PLoS One 2017; 12 (7): e0180143

PMC5049764 149. Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36.

PLoS One 2016; 11 (10): e0163889

PMC4911124 150. Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection.

PLoS One 2016; 11 (6): e0157887

PMC4769220 151. Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages.

PLoS One 2016; 11 (2): e0150568

PMC4414562 152. Delivery of GM-CSF to Protect against Influenza Pneumonia.

PLoS One 2015; 10 (4): e0124593

PMC4361055 153. Viral infection of human lung macrophages increases PDL1 expression via IFNbeta.

PLoS One 2015; 10 (3): e0121527

PMC4169489 154. Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages.

PLoS One 2014; 9 (9): e108138

PMC4148336 155. TLR ligands induce antiviral responses in chicken macrophages.

PLoS One 2014; 9 (8): e105713

PMC4126709 156. PI3K/Akt signaling pathway modulates influenza virus induced mouse alveolar macrophage polarization to M1/M2b.

PLoS One 2014; 9 (8): e104506

PMC3819268 157. ADAM17-mediated processing of TNF-alpha expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury.

PLoS One 2013; 8 (11): e79340

PMC3784437 158. Closely related influenza viruses induce contrasting respiratory tract immunopathology.

PLoS One 2013; 8 (9): e76708

PMC3655967 159. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.

PLoS One 2013; 8 (5): e64443

PMC3391237 160. Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.

PLoS One 2012; 7 (7): e40303

PMC3335012 161. The effect of rosuvastatin in a murine model of influenza A infection.

PLoS One 2012; 7 (4): e35788

PMC3292548 162. Innate immune response of human alveolar macrophages during influenza A infection.

PLoS One 2012; 7 (3): e29879

PMC3251590 163. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation.

PLoS One 2012; 7 (1): e29443

164. Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis.

PLoS Pathog 2020; 16 (2): e1008334

PMC6795447 165. Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling.

PLoS Pathog 2019; 15 (10): e1008062

PMC6364947 166. Influenza-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9.

PLoS Pathog 2019; 15 (1): e1007560

PMC5940246 167. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer.

PLoS Pathog 2018; 14 (4): e1007001

PMC5633202 168. Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology.

PLoS Pathog 2017; 13 (9): e1006640

PMC5268648 169. Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells.

PLoS Pathog 2017; 13 (1): e1006140

PMC5406035 170. RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection.

PLoS Pathog 2017; 13 (4): e1006326

PMC4701664 171. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.

PLoS Pathog 2016; 12 (1): e1005378

PMC4978498 172. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens.

PLoS Pathog 2016; 12 (8): e1005804

PMC4692439 173. Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection.

PLoS Pathog 2015; 11 (12): e1005338

PMC3974877 174. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection.

PLoS Pathog 2014; 10 (4): e1004053

PMC3777868 175. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection.

PLoS Pathog 2013; 9 (9): e1003615

PMC3585175 176. Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia.

PLoS Pathog 2013; 9 (2): e1003188

PMC3708851 177. Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.

PLoS Pathog 2013; 9 (7): e1003479

PMC3623797 178. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells.

PLoS Pathog 2013; 9 (4): e1003256

PMC3291650 179. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.

PLoS Pathog 2012; 8 (3): e1002570

PMC3207886 180. The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection.

PLoS Pathog 2011; 7 (11): e1002341

PMC3121882 181. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction.

PLoS Pathog 2011; 7 (6): e1002099

PMC3033375 182. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.

PLoS Pathog 2011; 7 (2): e1001271

PMC2483250 183. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.

PLoS Pathog 2008; 4 (8): e1000115

PMC6575592 184. BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.

Proc Natl Acad Sci U S A 2019; 116 (24): 11888-11893

PMC3896201 185. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.

Proc Natl Acad Sci U S A 2014; 111 (2): 769-74

PMC2635800 186. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection.

Proc Natl Acad Sci U S A 2009; 106 (5): 1560-5

PMC39817 187. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.

Proc Natl Acad Sci U S A 1996; 93 (6): 2448-53

PMC5756339 188. GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization.

Respir Res 2018; 19 (1): 3

PMC3520784 189. Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus.

Respir Res 2012; 13 (ä): 43

PMC2483272 190. Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice.

Respir Res 2008; 9 (ä): 53

191. Monoclonal antibody against human Tim-3 enhances antiviral immune response.

Scand J Immunol 2019; 89 (2): e12738

PMC6920369 192. Allergic inflammation alters the lung microbiome and hinders synergistic co-infection with H1N1 influenza virus and Streptococcus pneumoniae in C57BL/6 mice.

Sci Rep 2019; 9 (1): 19360

PMC5338329 193. IL-6 ameliorates acute lung injury in influenza virus infection.

Sci Rep 2017; 7 (ä): 43829

PMC5327488 194. Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47(phox).

Sci Rep 2017; 7 (ä): 43441

PMC5544693 195. SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection.

Sci Rep 2017; 7 (1): 7262

PMC5121658 196. Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus.

Sci Rep 2016; 6 (ä): 37815

PMC5181841 197. Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.

Sci Rep 2016; 6 (ä): 37045

PMC4926061 198. Cyclophilin A protects mice against infection by influenza A virus.

Sci Rep 2016; 6 (ä): 28978

PMC4901306 199. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition.

Sci Rep 2016; 6 (ä): 27912

PMC4672291 200. Early apoptosis of porcine alveolar macrophages limits avian influenza virus replication and pro-inflammatory dysregulation.

Sci Rep 2015; 5 (ä): 17999

PMC3982165 201. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice.

Sci Rep 2014; 4 (ä): 4638

PMC4927975 202. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Sci Transl Med 2011; 3 (78): 78ra32

PMC4896975 203. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology.

Semin Immunopathol 2016; 38 (4): 471-82

PMC3551428 204. Delta9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.

Toxicol Sci 2013; 131 (2): 419-33

PMC4165647 205. Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus.

Vet Pathol 2010; 47 (3): 378-86

PMC4259197 206. Intraepithelial T-cell cytotoxicity, induced bronchus-associated lymphoid tissue, and proliferation of pneumocytes in experimental mouse models of influenza.

Viral Immunol 2014; 27 (10): 484-96

PMC6381609 207. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response.

Virol J 2019; 16 (1): 21

PMC1781424 208. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.

Virol J 2007; 4 (ä): 9

PMC6286381 209. Lack of IFNgamma signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.

Virology 2019; 526 (ä): 155-164

210. heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-alpha/beta.

Virology 2019; 528 (ä): 80-88

PMC4157663 211. Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.

Virology 2014; 462-463 (ä): 254-65

212. The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus.

Virology 2013; 444 (1-2): 394-403

PMC2789846 213. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model.

Virology 2010; 396 (2): 178-88

214. Pathogenesis of influenza-induced acute respiratory distress syndrome.

Lancet Infect Dis 2014; 14 (1): 57-69

215. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.

Mol Cell Biochem 1981; 41 (ä): 3-12

216. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.

Mol Pharm 2012; 9 (9): 2710-8

217. NADPH oxidases as novel pharmacologic targets against influenza A virus infection.

Mol Pharmacol 2014; 86 (6): 747-59

218. NMP4 regulates the innate immune response to influenza A virus infection.

Mucosal Immunol 2020; ä (ä): ä

219. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.

Nat Med 2008; 14 (5): 558-64

220. Type I interferons in infectious disease.

Nat Rev Immunol 2015; 15 (2): 87-103

221. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Nature 1977; 267 (5609): 354-6

222. Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha.

Pathobiology 1991; 59 (4): 227-31

223. Macrophages and respiratory viruses.

Pathol Biol (Paris) 1997; 45 (2): 184-92

224. Vergleich zellularer und humoraler Immunitat gegen Influenzavirus beim Meerschweinchen

Pathol Microbiol (Basel) 1974; 40 (3): 231-33

225. Pathology of the swine-origin influenza A (H1N1) flu.

Pathol Res Pract 2011; 207 (2): 86-90

226. Macrophage activation syndrome induced by A/H1N1 influenza in cystic fibrosis.

Pediatr Pulmonol 2014; 49 (2): E10-2

PMC2613797 227. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses.

Virology 2008; 381 (1): 22-8

228. No apoptotic deaths and different levels of inductions of inflammatory cytokines in alveolar macrophages infected with influenza viruses.

Virology 2004; 329 (2): 270-9

PMC6630660 229. Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection.

Viruses 2019; 11 (6): ä

PMC6116029 230. Swine Influenza Virus Induces RIPK1/DRP1-Mediated Interleukin-1 Beta Production.

Viruses 2018; 10 (8): ä

PMC6115886 231. Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.

Viruses 2018; 10 (8): ä

232. [The influence of glucocorticoid immunosuppression on the course of experimental influenza pneumonia].

Vestn Ross Akad Med Nauk 2006; ä (6): 22-7

233. A new strategy of immune evasion by influenza A virus: inhibition of monocyte differentiation into dendritic cells.

Vet Immunol Immunopathol 2010; 136 (3-4): 201-10

234. Canine H3N8 influenza virus infection in dogs and mice.

Vet Pathol 2010; 47 (3): 507-17

235. Canine influenza virus replicates in alveolar macrophages and induces TNF-alpha.

Vet Pathol 2009; 46 (6): 1187-96

236. Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus.

Vet Pathol 2009; 46 (1): 138-41

237. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).

Vet Pathol 2003; 40 (3): 304-10

238. Localization of swine influenza virus in naturally infected pigs.

Vet Pathol 2002; 39 (1): 10-6

239. Histopathological changes in the upper respiratory tract of F344 rats following infection with a rat-adapted influenza virus.

Vet Pathol 1996; 33 (4): 412-8

240. Pathological lesions in the lungs of ducks infected with influenza A viruses.

Vet Pathol 1989; 26 (1): 1-5

PMC6534095 241. Targeting Peroxisome Proliferator-Activated Receptor-Gamma Decreases Host Mortality After Influenza Infection in Obese Mice.

Viral Immunol 2019; 32 (4): 161-169

242. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus.

Viral Immunol 2011; 24 (2): 77-88

243. The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling.

Virchows Arch 2004; 444 (1): 36-42

PMC6889097 244. The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection.

Virol Sin 2019; 34 (6): 648-661

245. IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.

Virology 2020; 540 (ä): 17-22

246. Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses.

Virology 1985; 140 (1): 192-6

247. Immune responses to influenza virus infection.

Virus Res 2011; 162 (1-2): 19-30

248. Active and inactive influenza virus induction of tumor necrosis factor-alpha and nitric oxide in J774.1 murine macrophages: modulation by interferon-gamma and failure to induce apoptosis.

Virus Res 2003; 97 (2): 117-26

249. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis.

Virus Res 1996; 44 (2): 79-95

250. [Pulmonary pathology in fatal human influenza A (H1N1) infection].

Zhonghua Bing Li Xue Za Zhi 2011; 40 (12): 825-9

251. [Histologic and ultrastructural studies of the patient died of highly pathogenic H5N1 avian influenza virus infection in China].

Zhonghua Bing Li Xue Za Zhi 2008; 37 (3): 150-4

252. [Pathologic changes caused by highly pathogenic H5N1 avian influenza virus: postmortem study of a case].

Zhonghua Bing Li Xue Za Zhi 2006; 35 (9): 545-8

253. [Distribution of influenza A (H5N1) virus and pathological lesions in major organ tissues of experimentally infected rhesus macaques].

Zhonghua Jie He He Hu Xi Za Zhi 2014; 37 (9): 682-6